Viewing Study NCT07250594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT07250594
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma
Sponsor: Advagene Biopharma Co. Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eosinophilic Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eosinophile View
None Type 1 interferon View
None Type 2 cytokines View
None Immunomodulator View
None eosinophilic asthma View
None intranasal View
None self-applicable View